BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37505117)

  • 1. Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship.
    Wijnands AM; Elias SG; Dekker E; Fidder HH; Hoentjen F; Ten Hove JR; Maljaars PWJ; van der Meulen-de Jong AE; Mooiweer E; Ouwehand RJ; Penning de Vries BBL; Ponsioen CY; van Schaik FDM; Oldenburg B;
    United European Gastroenterol J; 2023 Sep; 11(7):612-620. PubMed ID: 37505117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
    Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC
    Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.
    Rubin DT; Huo D; Kinnucan JA; Sedrak MS; McCullom NE; Bunnag AP; Raun-Royer EP; Cohen RD; Hanauer SB; Hart J; Turner JR
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1601-8.e1-4. PubMed ID: 23872237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia.
    de Jong ME; Nagtegaal ID; Vos S; van der Post RS; van Herwaarden Y; Derikx LAAP; Hoentjen F
    Dig Dis Sci; 2022 Dec; 67(12):5647-5656. PubMed ID: 35380348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.
    Mahmoud R; Shah SC; Ten Hove JR; Torres J; Mooiweer E; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH;
    Gastroenterology; 2019 Apr; 156(5):1333-1344.e3. PubMed ID: 30529584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette Smoke Increases Risk for Colorectal Neoplasia in Inflammatory Bowel Disease.
    van der Sloot KWJ; Tiems JL; Visschedijk MC; Festen EAM; van Dullemen HM; Weersma RK; Kats-Ugurlu G; Dijkstra G
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):798-805.e1. PubMed ID: 33453400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nancy Index Scores of Chronic Inflammatory Bowel Disease Activity Associate With Development of Colorectal Neoplasia.
    Kirchgesner J; Svrcek M; Le Gall G; Landman C; Dray X; Bourrier A; Nion-Larmurier I; Hoyeau N; Sokol H; Seksik P; Cosnes J; Fléjou JF; Beaugerie L;
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):150-157.e1. PubMed ID: 31085339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
    Singh S; Khanna S; Pardi DS; Loftus EV; Talwalkar JA
    Inflamm Bowel Dis; 2013 Jul; 19(8):1631-8. PubMed ID: 23665966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
    Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH; Jiang XL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
    Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA
    Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps.
    Wolf T; Lewis A; Beaugerie L; Svrcek M; Kirchgesner J;
    Aliment Pharmacol Ther; 2023 Jun; 57(12):1445-1452. PubMed ID: 37002640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of high-grade dysplasia and colorectal cancer in inflammatory bowel disease patients with recurrent low-grade dysplasia.
    de Jong ME; Kanne H; Nissen LHC; Drenth JPH; Derikx LAAP; Hoentjen F
    Gastrointest Endosc; 2020 Jun; 91(6):1334-1342.e1. PubMed ID: 31923409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and incidence of colorectal stricture progressing to colorectal neoplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Zhan Y; Cheng X; Mei P; Wu J; Ou Y; Cui Y
    Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1075-1087. PubMed ID: 37577790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.